{"id":37070,"date":"2019-07-26T08:22:43","date_gmt":"2019-07-26T16:22:43","guid":{"rendered":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2019\/07\/26\/gw-pharmas-cannabis-drug-okd-by-european-medicines-agency-panel\/"},"modified":"2019-07-26T12:41:27","modified_gmt":"2019-07-26T20:41:27","slug":"gw-pharmas-cannabis-drug-okd-by-european-medicines-agency-panel","status":"publish","type":"post","link":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2019\/07\/26\/gw-pharmas-cannabis-drug-okd-by-european-medicines-agency-panel\/","title":{"rendered":"GW Pharma\u2019s cannabis drug OK\u2019d by European Medicines Agency panel"},"content":{"rendered":"<\/p>\n<p>GW Pharmaceuticals announced\u00a0that the Committee for Medicinal Products for Human Use (CHMP) recommended approval of the British company\u2019s cannabis-based medicine Epidiolex. The CHMP is responsible for preparing the European Medicines Agency (EMA)\u2019s opinions on questions related to the marketing of human medicines. The CHMP opinion was adopted July 25, and the final decision now rests [\u2026]<\/p>\n<p><a rel=\"nofollow\" href=\"https:\/\/mjbizdaily.com\/gw-pharma-cannabis-medicine-approved-by-european-medicines-agency-panel\/\">GW Pharma\u2019s cannabis drug OK\u2019d by European Medicines Agency panel<\/a> is a post from: <a href=\"http:\/\/mjbizdaily.com\">Marijuana Business Daily: Financial, Legal &amp; Cannabusiness news for cannabis entrepreneurs<\/a><\/p>\n<p>&#013;<br \/>\n&#013;<br \/>\nRead More: <a href=\"https:\/\/mjbizdaily.com\/gw-pharma-cannabis-medicine-approved-by-european-medicines-agency-panel\/\" target=\"_blank\">GW Pharma\u2019s cannabis drug OK\u2019d by European Medicines Agency panel<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>GW Pharmaceuticals announced\u00a0that the Committee for Medicinal Products for Human Use (CHMP) recommended approval of the British company\u2019s cannabis-based medicine Epidiolex. The CHMP is responsible for preparing the European Medicines Agency (EMA)\u2019s opinions on questions related to the marketing of human medicines. The CHMP opinion was adopted July 25, and<span class=\"more-link\"><a href=\"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2019\/07\/26\/gw-pharmas-cannabis-drug-okd-by-european-medicines-agency-panel\/\">Continue Reading<\/a><\/span><\/p>\n","protected":false},"author":282,"featured_media":0,"comment_status":"false","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[9662,3156,9664,1393,2786,8940,9663],"tags":[],"_links":{"self":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/37070"}],"collection":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/users\/282"}],"replies":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/comments?post=37070"}],"version-history":[{"count":1,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/37070\/revisions"}],"predecessor-version":[{"id":37071,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/37070\/revisions\/37071"}],"wp:attachment":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/media?parent=37070"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/categories?post=37070"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/tags?post=37070"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}